Functional epitope mapping of insulin-like growth factor I (IGF-I) by anti-IGF-I monoclonal antibodies

Endocrinology

Volumn 138, Issue 3, 1997, Pages 905-915

  Mañes, Santos ^a   Kremer, Leonor ^a   Albar, Juan Pablo ^a   Mark, Catherine ^a   Llopis, Rafael ^a,b   Martínez A, Carlos ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b Fundación Club de Inversores   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ANTIBODY AFFINITY; ANTIGEN BINDING; ARTICLE; CROSS REACTION; ENZYME IMMUNOASSAY; HORMONE RECEPTOR INTERACTION; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031047635     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.3.4965     Document Type: Article

References (52)

1. Williams GT, Smith CA, Spooncer E, Dexter TM, Taylor DR 1990 Haemopietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343:76-79
2. Funk PE, Kincade PW, Witte PL 1994 Native associations of early hematopoietic stem cells and stromal cells isolated in bone marrow cell aggregates. Blood 83:361-369
3. Landreth KS, Narayanan R, Dorshkind K 1992 Insulin-like growth facror-I regulates pro-B cell differentiation. Blood 80:1207-1212
4. Rinderknecht E, Humbel RE 1978 The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 253:2769-2776
5. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
6. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E, Jacobs S, Francke U, Ramachandran J, Fujita-Yamaguchi Y 1986 Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5:2503-2512
7. Roth RA 1988 Structure of the receptor for insulin-like growth factor II: the puzzle amplified. Science 239:1269-1271
8. Zapf J, Waldvogel M, Froesch ER 1975 Binding of nonsuppressible insulin-like activity to human serum. Evidence for a carrier protein. Arch Biochem Biophys 168:638-645
9. Hintz RL, Liu F 1977 Demonstration of specific plasma protein binding sites for somatomedin. J Clin Endocrinol Metab 45:988-995
10. Ballard FJ, Watton PE, Bastian S, Tomas FM, Wallace JC, Francis GL 1993 Effects of interactions between IGFBPs and IGFs on the plasma clearance and in vivo biological activities of IGFs and IGF analogs. Growth Regul 3:40-48
11. Bar RS, Clemmons DR, Boes M, Busby WH, Booth BA, Dake BL, Sandra A 1990 Transcapillary permeability and subendothelial distribution of endothelial and amniotic fluid insulin-like binding proteins in the rat heart. Endocrinology 127:1078-1086
12. Ritvos O, Ranta T, Jalkanen J, Suikkari AM, Voutilainen R, Bohn H, Rutanen EM 1988 Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. Endocrinology 122:2150-2157
13. Pratt SE, Pollak MN 1994 Insulin-like growth factor binding protein 3 inhibits estrogen-stimulated breast cancer cell proliferation. Biochem Biophys Res Commun 198:292-297
14. De Mellow JSM, Baxter RC 1988 Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Commun 156:199-204
15. Elgin RG, Busby WH, Clemmons DR 1987 An insulin-like growth factor binding protein enhances the biological response to IGF-I. Proc Natl Acad Sci USA 84:3254-3258
16. Blum WF, Jenne EW, Reppin F. Kietzmann K, Ranke MB, Bierich JR 1989 Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I. Endocrinology 125:766-772
17. Stuart CA, Meehan RT, Neale LS, Cintron NM, Furlanetto RW 1991 Insulin-like growth factor-I binds selectively to human peripheral blood monocytes and B-lymphocytes. J Clin Endocrinol Metab 72:1117-1120
18. Eshet R, Werner H, Klinger B, Silbergeld A, Laron Z, LeRoith D, Roberts CT 1993 Up-regulation of insulin-like growth factor-I (JGF-I) receptor gene expression in patients with reduced serum IGF-I levels. J Mol Endocrinol 10:115-120
19. Rodríguez-Tarduchy G, Collins MKL, Garcia I, López-Rivas A 1992 Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells. J Immunol 149:535-540
20. Campbell RK, Matzuk MM, Canfield RE, Boime I, Moyle WR 1988 Use of monoclonal antibodies and mutagenesis to study the structure of human chorionic gonadotropin (hCG). In: Mochizuki M, Hussa R (eds) Placental Protein Hormones. Elsevier Science Publishers, New York, pp 123-128
21. Cascieri MA, Bayne ML, Ber E, Green BG, Men GW, Chicchi GG 1990 Identification of the insulin-like growth factor I (1GF-I) epitopes recognized by monoclonal and polyclonal antibodies to IGF-I. Endocrinology 126:2773-2777
22. Stewart CEH, Bates PC, Calder TA, Woodall SM, Pell JM 1993 Potentiation of insulin-like growth factor-I (IGF-I) activity by an antibody: supportive evidence for enhancement of IGF-I bioavailability in vivo by IGF binding proteins. Endocrinology 133:1462-1465
23. Kearney JF, Radbruch A, Liesegang B, Rajewsky K 1979 A new mouse myeloma line that has lost immunoglobulin expression that permits the construction of antibody secreting hybrids lines. J Immunol 123:1548-1550
24. Palacios R, Steinmetz M 1985 IL-3-dependent mouse clones that express B220 surface antigen, contain 1g genes in germ-line configuration, and generate B lymphocytes. Cell 41:727-734
25. Gellerfors P, Axelsson K, Helander A, Johansson S, Kenne L, Lindqvist S, Pavlu B, Skottner A, Fryklund L 1989 Isolation and characterization of a glycosylated form of insulin-like growth factor I produced in Saccharumyces cerevisiae. J Biol Chem 264:11444-11449
26. Tijssen P 1985 Preparation of enzyme-antibody or other enzyme-macromolecule conjugates. In: Burdon RH, van Knippenberg PH (eds) Laboratory Techniques in Biochemistry and Molecular Biology. Elsevier Science Publishers, New York, pp 221-296
27. Atherton E, Sheppard RC (eds) 1989 Solid Phase Synthesis: A Practical Approach. IRL Press, Oxford
28. Galfre G, Howe SC, Milstein C, Butcher GW, Howard JC 1977 Antibodies to major histocompatibility antigens produced by hybrid cell lines. Nature 266:550-552
29. Harlow E, Lane D 1988 Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Plainview NY
30. Wofsy L 1983 Methods and applications of hapten-sandwich labeling. Methods Enzymol 92:472-488
31. VanCott TC, Loomis LD, Redfield RR, Birx DL 1992 Real-time biospecific interaction analysis of antibody reactivity to peptides from the envelope glycoprotein, gp160, of HIV-1. J Immunol Methods 146:163-176
32. Hintz RL, Liu F, Marshall LB, Chang D 1980 Interaction of somatomedin-C with an antibody directed against the synthetic C-peptide of insulin-like growth factor-I. J Clin Endocrinol Metab. 50:405-407
33. Maly P, Lüthi C 1986 Characterization of affinity-purified Type-1 insulin-like growth factor receptor from human placenta. Biochem Biophys Res Commun 138:1257-1262
34. Christoffersen CT, Bornfeldt KE, Rotella CM, Gonzales N, Vissing H, Shymko RM, Hoeve J, Groffen J, Heisterkamp N, De Meyts P 1994 Negative cooperativity in the insulin-like growth factor-I receptor and chimeric IGF-I/ insulin receptor. Endocrinology 135:472-475
35. Benjamin DC, Berzofsky JA, East IJ, Gurd FRN, Hannum C, Leach SJ, Margoliash E, Michael JG, Miller A, Prager EM, Reichlin M, Sercarz EE, Smith-Gill SJ, Todd PE, Wilson AC 1984 The antigenic structure of proteins: a reappraisal. Annu Rev Immunol 2:67-101
36. Wilson IA, Stanfield RL 1994 Antibody-antigen interactions: new structures and new conformational changes. Curr Op Struct Biol 4:857-867
37. Kabsch W, Sander C 1983 Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22:2577-2637
38. Harvey D, Jones WT, Jones SD, Ryan GB 1993 Production of monoclonal antibodies recognising different epitopes present on insulin-like growth factor-I. Hybridoma 12:737-744
39. Bayne ML, Applebaum J, Chicchi GG, Hayes NS, Green BG, Cascieri MA 1988 Structural analogs of insulin-like growth facror-I with reduced affinity for serum binding proteins and the Type-2 insulin-like growth factor receptor. J Biol Chem 263:6233-6237
40. Clemmons DR, Dehoff ML, Busby WH, Bayne ML, Cascieri MA 1992 Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4 and 5 by the IGFs and IGF analogs. Endocrinology 131:890-895
41. Bayne ML, Applebaum J, Underwood D, Chicchi GG, Green BG, Hayes NS, Cascieri MA 1989 The C-region of human insulin-like growth factor (IGF) I is required for high affinity binding to the Type-1 IGF receptor. J Biol Chem 264:11004-11008
42. Cooke RM, Harvey TS, Campbell ID 1991 Solution structure of human insulin-like growth factor 1: a nuclear magnetic resonance and restrained molecular dynamics study. Biochemistry 30:5484-5491
43. Pietrzkowski Z, Wernicke D, Porcu P, Jameson BA, Baserga R1992 Inhibition of cellular proliferation by peptide analogues of insulin-like growth factor 1. Cancer Res 52:6447-6451
44. Clemmons DR, Cascieri MA, Camacho-Hubner C, McCusker RH, Bayne ML 1990 Discrete alterations of the insulin-like growth factor I molecule which alter its affinity for insulin-like growth factor-binding proteins result in changes in bioactivity. J Biol Chem 265:12210-12216
45. Jones JI, D'Ercole AJ, Camacho-Hubner C, Clemmons DR 1991 Phosphorylation of insulin-like growth factor binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I. Proc Natl Acad Sci USA 88:7481-7485
46. Kinoshita T, Yokota T, Arai K, Miyajima A 1995 Suppression of apoptosis death in hematopoietic cells by signalling through the IL-3/GM-CSF receptors. EMBO J 14:266-275
47. Harrington EA, Bennett MR, Fanidi A, Evan GI 1994 c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 13:3286-3295
48. Kaleko M, Rutter WG, Miller AD 1990 Overexpression of the human insulin-like growth factor 1 receptor promotes ligand-dependent neoplastic transformation. Mol Cell Biol 10:464-473
49. Sell C, Rubini M, Rubin R, Liu J-P, Efstratiadis A, Baserga R 1993 Simian virus 40 large tumor antigen is unable to transform fibroblasts lacking Type-1 insulin-like growth factor receptor. Proc Natl Acad Sci USA 90:11217-11221
50. Sell C, Dumenil G, Deveaud C, Miura M, Coppola D, DeAngelis T, Rubin R, Efstratiadis A, Baserga R 1994 Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol Cell Biol 14:3604-3612
51. Resnicoff M, Sell C, Rubini M, Coppola D, Ambrose D, Baserga R, Rubin R 1994 Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Res 54:2218-2222
52. Porcu P, Ferber A, Pietrzkowski Z, Roberts CT, Adamo M, LeRoith D, Baserga R 1992 The growth stimulatory effect of simian virus 40 T antigen requires the interaction of insulin-like growth factor I with its receptor. Mol Cell Biol 12:5069-5077